Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.482
Neutral
RSI(14)
37.258
Neutral
STOCH(KDJ)(9,3,3)
39.952
Neutral
ATR(14)
24.711
High Vlolatility
CCI(14)
16.866
Neutral
Williams %R
71.353
Sell
TRIX(12,20)
-0.758
Sell
StochRSI(14)
85.819
Buy
Thermo Fisher Scientific Inc
TMOView Detailed Chart
431.640USD
-3.770-0.87%
Close 04/23, 16:00（ET）Quotes delayed by 15 min
164.36BMarket Cap
25.94P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.87%
5 Days
-1.18%
1 Month
-16.63%
6 Months
-25.13%
Year to Date
-17.03%
1 Year
-24.88%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
33
analysts
BUY
Current Rating
626.614
Target Price
44.14%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Thermo Fisher Scientific Inc
TMO
33
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Intuitive Surgical Inc
ISRG
33
Veeva Systems Inc
VEEV
32
Danaher Corp
DHR
28
1
2
3
...
18
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Sell
Moving Average
Indicators
Value
Direction
MA5
430.502
Buy
MA10
436.177
Sell
MA20
456.101
Sell
MA50
497.862
Sell
MA100
522.245
Sell
MA200
552.579
Sell
News
Thermo Fisher Scientific To Acquire Solventum’S Purification And Filtration Business
Feb 25 (Reuters) - Thermo Fisher Scientific Inc TMO.N:THERMO FISHER SCIENTIFIC TO ACQUIRE SOLVENTUM’S PURIFICATION AND FILTRATION BUSINESSTHERMO FISHER SCIENTIFIC INC - TO ACQUIRE SOLVENTUM'S PURIFICATION & FILTRATION BUSINESS FOR $4.1 BILLIONTHERMO FISHER SCIENTIFIC INC - TRANSACTION EXPECT...
ReutersTue, Feb 25
Thermo Fisher Scientific Inc reports results for the quarter ended December 31 - Earnings Summary
Thermo Fisher Scientific Inc TMO.N reported quarterly adjusted earnings of $6.10 per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $5.67. The mean expectation of twenty five analysts for the quarter was for earnings of $5.94...
ReutersThu, Jan 30
Company
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, the Company provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, the Company provides an offering of instruments and the supporting consumables, software and services that are used for a range of applications. The Company’s Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
Company codeTMO
CompanyThermo Fisher Scientific Inc
CEOMr. Marc N. Casper
Websitehttps://www.thermofisher.com/
